World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
114
Citations
43467
World Ranking
4781
National Ranking
2591

Overview

Arie S. Belldegrun is affiliated with the University of California, Los Angeles in the United States. Their research primarily focuses on medicine, with significant contributions in pulmonary and respiratory medicine, radiology, nuclear medicine and imaging, surgery, oncology, and rheumatology.

The scientist's work covers multiple topics within their field, including prostate cancer diagnosis and treatment, prostate cancer treatment and research, kidney stones and urolithiasis treatments, radiopharmaceutical chemistry and applications, radiation dose and imaging, genital health and disease, and advanced X-ray and CT imaging.

Frequent co-authors in their research include Riemer A. Kingma, Stijn Roemeling, Bertrand Tombal, Derya Yakar, and Emanuela Altobelli.

They have published extensively in several venues, with notable appearances in:

  • European Urology Open Science
  • European Urology
  • Journal of Clinical Oncology
  • British Journal of Urology
  • BMC Cancer

Some of their recent scholarly papers include:

  • European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer, 2023, European Urology
  • A deep learning masked segmentation alternative to manual segmentation in biparametric MRI prostate cancer radiomics, 2022, European Radiology
  • Prevalence of Peyronie and Ledderhose Diseases in a Series of 730 Patients with Dupuytren Disease, 2020, Plastic & Reconstructive Surgery
  • A Prospective Multicenter Comparison Study of Risk-adapted Ultrasound-directed and Magnetic Resonance Imaging-directed Diagnostic Pathways for Suspected Prostate Cancer in Biopsy-naïve Men, 2022, European Urology
  • Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy, 2020, British Journal of Cancer

Best Publications

  • Guideline for management of the clinical T1 renal mass.

    Steven C Campbell;Andrew C Novick;Arie S. Belldegrun;Michael L Blute

  • THE CHANGING NATURAL HISTORY OF RENAL CELL CARCINOMA

    Allan J. Pantuck;Amnon Zisman;Arie S. Belldegrun

  • Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease.

    Nicolette K Janzen;Hyung L Kim;Robert A Figlin;Arie S Belldegrun

  • Improved Prognostication of Renal Cell Carcinoma Using an Integrated Staging System

    Amnon Zisman;Allan J. Pantuck;Fredrick Dorey;Jonathan W. Said

  • Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience

    Jean Jacques Patard;Emmanuelle Leray;Nathalie Rioux-Leclercq;Luca Cindolo

  • Risk Group Assessment and Clinical Outcome Algorithm to Predict the Natural History of Patients With Surgically Resected Renal Cell Carcinoma

    Amnon Zisman;Allan J. Pantuck;Jeffery Wieder;Debby H. Chao

  • Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: Implications for prognosis and therapy

    Matthew H.T. Bui;David Seligson;Ken ryu Han;Allan J. Pantuck

  • SAFETY AND EFFICACY OF PARTIAL NEPHRECTOMY FOR ALL T1 TUMORS BASED ON AN INTERNATIONAL MULTICENTER EXPERIENCE

    Jean-Jacques Patard;Oleg Shvarts;John S. Lam;Allan J. Pantuck

  • Carbonic Anhydrase IX Is an Independent Predictor of Survival in Advanced Renal Clear Cell Carcinoma

    Matthew H. T. Bui;David Seligson;Ken-ryu Han;Allan J. Pantuck

  • Phase II Study of Pomegranate Juice for Men with Rising Prostate-Specific Antigen following Surgery or Radiation for Prostate Cancer

    Allan J. Pantuck;John T. Leppert;Nazy Zomorodian;William Aronson

  • Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.

    Ke-Hung Tsui;Oleg Shvarts;Robert B. Smith;Robert A. Figlin

  • Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice.

    Karen A. Klein;Robert E. Reiter;James Redula;Hamid Moradi

  • Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.

    John S. Lam;Oleg Shvarts;John T. Leppert;Robert A. Figlin

  • Use of the University of California Los Angeles Integrated Staging System to Predict Survival in Renal Cell Carcinoma: An International Multicenter Study

    Jean Jacques Patard;Hyung L. Kim;John S. Lam;Frederick J. Dorey

  • RENAL CELL CARCINOMA: PROGNOSTIC SIGNIFICANCE OF INCIDENTALLY DETECTED TUMORS

    Ke-Hung Tsui;Oleg Shvarts;Robert B. Smith;Robert Figlin

  • Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy.

    Allan J. Pantuck;David B. Seligson;Tobias Klatte;Hong Yu

  • Evidence for Clonal Outgrowth of Androgen-independent Prostate Cancer Cells from Androgen-dependent Tumors through a Two-Step Process

    Noah Craft;Chloe Chhor;Chris Tran;Arie Belldegrun

  • Efficacy of Nephron-Sparing Surgery for Renal Cell Carcinoma: Analysis Based on the New 1997 Tumor-Node-Metastasis Staging System

    Arie Belldegrun;Ke-Hung Tsui;Jean B. deKernion;Robert B. Smith

  • Pomegranate Ellagitannin-Derived Metabolites Inhibit Prostate Cancer Growth and Localize to the Mouse Prostate Gland

    Navindra P. Seeram;William J. Aronson;Yanjun Zhang;Susanne M. Henning

  • Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience

    J.-J. Patard;E. Leray;N. Rioux-Leclercq;L. Cindolo

Frequent Co-Authors

Allan J. Pantuck
Allan J. Pantuck University of California, Los Angeles
Robert A. Figlin
Robert A. Figlin Cedars-Sinai Medical Center
Jonathan W. Said
Jonathan W. Said University of California, Los Angeles
Alexandre de la Taille
Alexandre de la Taille Université Paris Cité
Laurent Salomon
Laurent Salomon Necker-Enfants Malades Hospital
Steve Horvath
Steve Horvath University of California, Los Angeles
Frederick J. Dorey
Frederick J. Dorey University of California, Los Angeles
Peter F.A. Mulders
Peter F.A. Mulders Radboud University
Stephen J. Freedland
Stephen J. Freedland Cedars-Sinai Medical Center
William H. McBride
William H. McBride University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in Medicine but seeking flexible study options, online healthcare degrees are becoming increasingly popular. Many students start their medical careers by considering affordable online fnp programs (Family Nurse Practitioner), which provide a foundation for advanced practice and direct patient care roles.

For those looking to begin or advance their nursing career, exploring nursing school online offers the benefit of a flexible schedule and access to top-tier education from anywhere. These programs help address the growing demand for skilled nurses across the country.

If you already hold a registered nursing license, moving to a bachelor’s degree can open further opportunities. The cheapest rn to bsn programs allow you to upgrade your qualifications in less time and at lower cost, furthering your clinical expertise and professional growth.

For those aiming for leadership, teaching, or research positions, online phd programs in nursing can provide the advanced knowledge and credentials needed to shape the future of healthcare. Carefully compare program costs, accreditation, and curriculum to find the best fit for your career goals.

Best Scientists Citing Arie S. Belldegrun

Trending Scientists